Literature DB >> 20690385

The reality of subclinical hypothyroidism in general practice.

Veronique Gibbons1, Steven Lillis, John Conaglen, Ross Lawrenson.   

Abstract

INTRODUCTION: Subclinical hypothyroidism (SCH) is common, reported to affect 4-10% of the adult population. Recommendations for treatment of SCH are contentious, with protagonists even disagreeing over the rationale for medical intervention. How general practitioners (GPs) manage patients with elevated thyroid stimulating hormone (TSH) and normal thyroid hormone results are unknown. This study aimed to explore how GPs think about diagnosing and managing SCH.
METHODS: A qualitative study using focus groups conducted between December 2007 and March 2008 to understand how GPs perceive SCH and their diagnostic and management process.
FINDINGS: Thirteen GPs in three focus groups in Waikato, New Zealand participated. There is wide variability in how GPs perceive SCH and their knowledge of the disease. A patient-centred approach to diagnosis and management was commonly reported. Consideration of overt pathology and medicolegal issues also influenced perceptions of SCH, but lack of evidence regarding outcomes of treatment made such issues complex.
CONCLUSION: SCH remains a complex entity because of ambiguity regarding symptoms, uncertainty regarding prognosis and variation in advice regarding treatment. This complexity is reflected in the disparate responses by GPs to the diagnosis and management of SCH.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20690385

Source DB:  PubMed          Journal:  J Prim Health Care        ISSN: 1172-6156


  2 in total

1.  Increase in Thyrotropin Is Associated with an Increase in Serum Prolactin in Euthyroid Subjects and Patients with Subclinical Hypothyroidism.

Authors:  Vahid Sheikhi; Zahra Heidari
Journal:  Med J Islam Repub Iran       Date:  2021-12-15

2.  International variation in GP treatment strategies for subclinical hypothyroidism in older adults: a case-based survey.

Authors:  Wendy P J den Elzen; Anne A Lefèbre-van de Fliert; Vanessa Virgini; Simon P Mooijaart; Peter Frey; Patricia M Kearney; Ngaire Kerse; Christian D Mallen; Vera J C McCarthy; Christiane Muth; Thomas Rosemann; Audrey Russell; Henk Schers; David J Stott; Margot W M de Waal; Alex Warner; Rudi G J Westendorp; Nicolas Rodondi; Jacobijn Gussekloo
Journal:  Br J Gen Pract       Date:  2015-02       Impact factor: 5.386

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.